According to a loving tribute from Methodist Health System, Matthew Latacha, MD, was “well respected, admired and loved by patients, colleagues and staff.” The incident is still under investigation. 

The complaint describes Medtronic's actions as “immoral, unethical, oppressive and unscrupulous.”

"I think everyone would agree that the current fee-for-service model is not working appropriately and there needs to be a fix," regulatory consultant Denise Garris explained in a new interview. 

We already screen patients for breast cancer and lung cancer on a regular basis. Why not establish screening programs for aortic stenosis?

Advances in AI technology are expected to give physicians more time to provide high-quality care to their patients.

The ACC has joined forces with Amgen and Esperion Therapeutics to increase LDL screening in patients with and without a history of cardiovascular issues.

The new device, the first of its kind to gain FDA approval, was designed for patients who have no other endovascular or surgical options available to them.

Shockwave and two other healthcare companies in the cardiovascular health space are considered attractive options for investors looking to expand their portfolios.